tiprankstipranks
Advertisement
Advertisement

JP:2395 Stock Latest News

Shin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs
Company AnnouncementsShin Nippon Biomedical Laboratories Keeps Annual Dividend at ¥50 as CRO Business Hits Record Highs
18d ago
2395
SNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall
PremiumCompany Announcements
SNBL backs U.S. launch build-out for migraine drug Atzumi after licensing talks stall
1M ago
2395
Shin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Outlines FY2026 Results and Strategic Focus
1M ago
2395
SNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push
PremiumCompany Announcements
SNBL Posts Flat Revenue, Lower Profits but Stronger Balance Sheet and Cash Ahead of FY2027 Growth Push
1M ago
2395
SNBL to Shift Meeting Leadership to Board Chair in Governance Revamp
PremiumCompany Announcements
SNBL to Shift Meeting Leadership to Board Chair in Governance Revamp
2M ago
2395
SNBL Revamps Top Management to Drive Long-Term Growth
PremiumCompany AnnouncementsSNBL Revamps Top Management to Drive Long-Term Growth
2M ago
2395
SNBL Releases Q3 FY2026 Results Briefing and Business Update
Premium
Company Announcements
SNBL Releases Q3 FY2026 Results Briefing and Business Update
4M ago
2395
SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher
Premium
Company Announcements
SNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast Higher
4M ago
2395
Shin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend Plan
4M ago
2395
SNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue
PremiumCompany Announcements
SNBL Warns of Added Costs as U.S. Migraine Drug Unit Talks Continue
5M ago
2395
Shin Nippon Biomedical Announces Interim Dividends
PremiumCompany Announcements
Shin Nippon Biomedical Announces Interim Dividends
7M ago
2395
Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Exceeds Financial Forecasts for H1 2025
7M ago
2395
Shin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits
PremiumCompany AnnouncementsShin Nippon Biomedical Laboratories Reports Increased Revenue but Declining Profits
7M ago
2395
Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025
Premium
Company Announcements
Shin Nippon Biomedical Laboratories Reports Mixed Financial Results for Q1 2025
11M ago
2395
Shin Nippon Biomedical Laboratories Announces Year-End Dividend
Premium
Company Announcements
Shin Nippon Biomedical Laboratories Announces Year-End Dividend
1y ago
2395
Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Corrects Financial Results for FY 2025
1y ago
2395
Shin Nippon Biomedical Reports Revenue Growth Amid Profit Decline
PremiumCompany Announcements
Shin Nippon Biomedical Reports Revenue Growth Amid Profit Decline
1y ago
2395
Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment
PremiumCompany Announcements
Satsuma Pharmaceuticals Gains FDA Approval for Migraine Treatment
1y ago
2395
SNBL and Tasso, Inc. Form Joint Venture to Distribute Blood Collection Device in Japan
PremiumCompany Announcements
SNBL and Tasso, Inc. Form Joint Venture to Distribute Blood Collection Device in Japan
1y ago
2395
SNBL’s SNLD to Present Nasal Levodopa Study at AAN 2025
PremiumCompany AnnouncementsSNBL’s SNLD to Present Nasal Levodopa Study at AAN 2025
1y ago
2395
Shin Nippon Biomedical Laboratories Ups Earnings Forecast for FY 2025
Premium
Company Announcements
Shin Nippon Biomedical Laboratories Ups Earnings Forecast for FY 2025
1y ago
2395
Shin Nippon Biomedical Laboratories Reports Revenue Growth Amid Profit Challenges
Premium
Company Announcements
Shin Nippon Biomedical Laboratories Reports Revenue Growth Amid Profit Challenges
1y ago
2395

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >